Literature DB >> 4697792

Impaired chemiluminescence during phagocytosis of opsonized bacteria.

R L Stjernholm, R C Allen, R H Steele, W W Waring, J A Harris.   

Abstract

A simple technique is presented for rapid screening of leukocytes of patients suspected of having a defective intracellular mechanism for the bactericidal and digestive disposal of bacteria.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4697792      PMCID: PMC422676          DOI: 10.1128/iai.7.2.313-314.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Microsomal ( S) chemiluminescence (CL) induced by NADPH and its relation to lipid peroxidation.

Authors:  R M Howes; R H Steele
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1971 Jul-Sep

2.  Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme.

Authors:  P E Stanley; S G Williams
Journal:  Anal Biochem       Date:  1969-06       Impact factor: 3.365

3.  Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity.

Authors:  R C Allen; R L Stjernholm; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

4.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

5.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

  5 in total
  34 in total

1.  Chemiluminescence response of human leukocytes: influence of medium components on light production.

Authors:  R D Nelson; M J Herron; J R Schmidtke; R L Simmons
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

2.  Changes in phagocytic function with glycaemic control in diabetic patients.

Authors:  S M MacRury; C G Gemmell; K R Paterson; A C MacCuish
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

3.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes.

Authors:  R C Allen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

5.  The origin of the chemiluminescence of phagocytosing granulocytes.

Authors:  B D Cheson; R L Christensen; R Sperling; B E Kohler; B M Babior
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

6.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

7.  Effects of cefodizime on non-specific immune functions in patients with multiple myeloma.

Authors:  F Dammacco; S Benvestito
Journal:  Infection       Date:  1992       Impact factor: 3.553

8.  Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro.

Authors:  R D Daimond; R Krzesicki
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

10.  X-linked inheritance in females with chronic granulomatous disease.

Authors:  E L Mills; K S Rholl; P G Quie
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.